PRQR
ProQR Therapeutics BV
1.70$
+1.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
ProQR Therapeutics BV (PRQR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -12 million EUR. Tick rows to compare them in a chart.
All figures in millions of EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.5 | -5.3 | -15 | -6.3 | -5.7 | -9.3 | -16 | -11 | -12 | -13 | -11 | -12 | -49 | |
| 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 2.8 | |
| 0.4 | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | 0.8 | 0.9 | 1.1 | 1.2 | 1.4 | 1.4 | 5.1 | |
| -2.0 | 2.3 | -9.2 | -4.6 | 1.1 | -0.5 | -6.7 | -1.2 | -3.1 | -6.3 | 0.1 | -5.8 | -15 | |
| 0.3 | 0.6 | 0.7 | 0.3 | 0.3 | 0.1 | 0.2 | 0.1 | 0.2 | 0.5 | 0.2 | 0.3 | 1.1 | |
| -0.3 | 5.0 | -18 | -0.3 | 17 | -2.8 | -0.2 | -0.1 | -0.2 | -0.5 | -0.2 | -0.3 | -1.1 | |
| – | – | – | – | -0.5 | -0.3 | -0.6 | -0.3 | -0.4 | -0.6 | -0.3 | -0.6 | -2.0 | |
| -0.3 | -1.1 | -0.4 | -0.3 | -0.5 | 71 | -0.5 | -0.3 | -0.4 | -0.6 | -0.3 | 49 | 48 | |
| -8.0 | -1.6 | -33 | -6.7 | 10 | 60 | -17 | -13 | -13 | -15 | -11 | 35 | -3.3 | |
| -7.8 | -5.9 | -16 | -6.5 | -5.9 | -9.5 | -16 | -12 | -12 | -14 | -11 | -13 | -50 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.